Medical Properties Trust (MPT) Cash & Equivalents (2009 - 2026)

Medical Properties Trust (MPT) has 18 years of Cash & Equivalents data on file, last reported at $425.0 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 36.89% year-over-year to $425.0 million in Q1 2026; TTM through Mar 2026 was $425.0 million, a 36.89% decrease from a year earlier, with the FY2025 full-year figure at $540.9 million, up 62.75% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $425.0 million, down from $540.9 million in the prior quarter.
• Over the last five years, Cash & Equivalents for MPT reached as high as $673.5 million in Q1 2025 and fell as low as $224.3 million in Q1 2024.
• Historically, Cash & Equivalents has averaged $367.2 million across 5 years, with a median of $324.0 million in 2023.
• Across the five-year window, Cash & Equivalents slumped 66.68% in 2022 and surged 200.21% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $235.7 million in 2022, then grew by 6.09% to $250.0 million in 2023, then jumped by 32.93% to $332.3 million in 2024, then surged by 62.75% to $540.9 million in 2025, then fell by 21.42% to $425.0 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $425.0 million in Q1 2026, $540.9 million in Q4 2025, and $396.6 million in Q3 2025.